Donors commit to fund the scale up of the ACT-Accelerator but warn additional funding is critical to support its success ... Nov 17
Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ... Nov 07
Ligand’s Partner Sedor Pharmaceuticals receives US FDA approval for SESQUIENT for the treatment of status epilepticus in adult and paediatric patients ... Nov 07
The pharma company aim to build a world-leading R&D and production platform depending on core talents and technical skills... Nov 07
-Advertisements-